PPLPHARMA — Piramal Pharma (Mumbai) Share News
0.000.00%
Last trade - 00:00- IN₹210.84bn
- IN₹253.37bn
- IN₹88.69bn
China robotaxis, Indian pharma among hedge fund top picks at Sohn Hong Kong
Brief: Piramal Pharma March-Qtr Consol Net Profit 1.54 Bln Rupees
Brief: Piramal Pharma Continues To Invest $90 Mln In Expansion Of Two US Sites
India's Piramal Pharma rises after Goldman Sachs initiates with "buy"
India's Piramal Pharma rises on UK nod for drug to treat hypotension in infants
Brief: Piramal Pharma Says Piramal Critical Care And BrePco Announces MHRA Approval For Neoatrico In UK
India's Piramal Enterprises hit with nearly $172 million tax bill for pharma deal (updated)
India's contract drug makers seek government support in China fight
At conference, drugmakers tout AI efforts as US tariffs cast shadow
Brief: Piramal Pharma Says US FDA Inspection At Turbhe Facility
Brief: Piramal Pharma Dec-Qtr Consol Net Profit 36.8 Mln Rupees
Brief: Piramal Pharma Gets GST Order With Penalty
Brief: Piramal Pharma Says Division Announces US Launch Of Chlorpromazine Hydrochloride For Injection
India's Piramal Pharma rises after JM Financial initiates with Street-high target price
Brief: Piramal Pharma Says Piramal Pharma Solutions Inc And VetDC, Inc Entered Into Settlement Agreement
India's Piramal Pharma gains on Q2 profit surge
Brief: Piramal Pharma Says Piramal Pharma Solutions Announces $80M Expansion Plan
India's Piramal Pharma gains after Jefferies raises target price
Brief: Piramal Pharma To Reduce GHG Emissions By 2030